HOME >> BIOLOGY >> NEWS
Sperm Protein May Hold Clues For Fertility And Contraceptives

A protein found on the surface of the sperm of all mammals appears crucial for the union of the sperm and egg, as well as for movement of the sperm into the animal's oviduct, announce researchers at the University of California, Davis.

The discovery, which has direct implications for human fertility research as well as development of male contraceptives, is reported in the Sept. 18 issue of the journal Science.

"We suspected that sperm lacking the protein known as fertilin-beta would not be able to penetrate the egg, but we were quite surprised that these sperm even failed to bind with the egg's outer coating and rarely were able to travel from the uterus to the oviduct," said researcher Chunghee Cho. He is a molecular biologist and postdoctoral fellow from Korea working in the laboratory of UC Davis fertility researchers Diana Myles and Paul Primakoff.

The researchers studied the activity of sperm in mice lacking the gene for fertilin-beta, which belongs to a family of proteins found on the surface of cells and is believed to be important in cell binding.

Sperm from the mutant mice looked and moved normally, but most of them failed to attach to the egg. These sperm fused with the plasma membrane, which encases the egg, at just half the rate of sperm from normal mice.

Cho and colleagues anticipated this binding failure at the plasma membrane, but were surprised that the defective sperm were not even binding with the zona pellucida, the thick transparent wall that forms the outermost covering of the egg.

Furthermore, the sperm lacking fertilin-beta seemed unable to migrate from the uterus into the oviduct where the eggs are housed. The researchers speculate that this may be because the mutant sperm were unable to temporarily cling to the lining of the juncture of the uterus and oviduct as they normally would before proceeding into the oviduct.

The fertility rate of the male mice lacking fertilin-beta was 98 percent less than that of the no
'"/>

Contact: Patricia Bailey
pjbailey@ucdavis.edu
(530) 752-9843
University of California - Davis
17-Sep-1998


Page: 1 2

Related biology news :

1. Sperm use heat sensors to find the egg
2. Sperm and germ-fighting contraceptive enters trials
3. Sperm counts unchanged over 50 years
4. Male Moths Sperm Protects Females
5. Eggs Fertilised By More Than One Sperm Can Survive
6. Gene Once Thought To Program Ovarian Development Instead Found To Be Critical For Production Of Sperm
7. Bacteria That Disable Sperm
8. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
9. The First Rejection: Eggs Sequester Bits Of Sperm For Later Elimination
10. Reanalysis Of International Data Finds Sharp Decline In Sperm Density
11. Stress Lowers Sperm Count By Overwhelming Cells That Make Testosterone

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sperm Protein May Hold Clues For Fertility And Contraceptives

(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
Cached News: